FDA Inspection 1121894 — Bloodworks
The FDA completed an inspection of Bloodworks on Mar 11, 2020 in Portland, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Portland, OR (United States)